Literature DB >> 12682423

Justification for antioxidant preconditioning (or how to protect insulin-mediated actions under oxidative stress).

A Orzechowski1.   

Abstract

Insulin resistance is characterized by impaired glucose utilization in the peripheral tissues, accelerated muscle protein degradation, impaired antioxidant defences and extensive cell death. Apparently, both insulin and IGF-1 at physiological concentrations support cell survival by phosphatidylinositol 3 kinase-dependent and independent mechanisms. Postprandial hyperglycemia and hyperinsulinemia are found in insulin resistance, which accompanies the so-called noninsulin dependent diabetes mellitus (diabetes type 2). Evidence also indicates that increased susceptibility of muscle cells and cardiomycoytes to oxidative stress is among the harmful complications of insulin resistance and diabetes. Limited knowledge showing benefits of preconditioning with anti- oxidants (vitamin C, E, a-lipoic acid, N-acetylcysteine) in order to protect insulin action under oxidative stress prompted the author to discuss the theoretical background to this approach. It should be stressed that antioxidant preconditioning is relevant to prevention of both diabetes- and insulin resistance-associated side-effects such as low viability and cell deletion. Furthermore, antioxidant conditioning promises to provide higher efficacy for clinical applications in myoblast transfer therapy and cardiomyoplasty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682423     DOI: 10.1007/BF02970130

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  126 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Oxygen(es) and the hypoxia-inducible factor-1.

Authors:  R H Wenger; M Gassmann
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

3.  Glucose transporter expression in L6 muscle cells: regulation through insulin- and stress-activated pathways.

Authors:  C Taha; T Tsakiridis; A McCall; A Klip
Journal:  Am J Physiol       Date:  1997-07

4.  Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways.

Authors:  A S Blair; E Hajduch; G J Litherland; H S Hundal
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

5.  Insulin-sensitive glucose transporter transcript levels in calf muscles assessed with a bovine GLUT4 cDNA fragment.

Authors:  J F Hocquette; B Graulet; C Castiglia-Delavaud; F Bornes; N Lepetit; P Ferre
Journal:  Int J Biochem Cell Biol       Date:  1996-07       Impact factor: 5.085

6.  Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway.

Authors:  D E Estrada; H S Ewart; T Tsakiridis; A Volchuk; T Ramlal; H Tritschler; A Klip
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

7.  The potential role of adenosine in the pathophysiology of the insulin resistance syndrome.

Authors:  S J Bakker; R O Gans; J C ter Maaten; T Teerlink; H V Westerhoff; R J Heine
Journal:  Atherosclerosis       Date:  2001-04       Impact factor: 5.162

8.  Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway.

Authors:  M V Chakravarthy; T W Abraha; R J Schwartz; M L Fiorotto; F W Booth
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 9.  Redox signals that regulate the vascular response to injury.

Authors:  B C Berk
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

10.  Calorie restriction increases cell surface GLUT-4 in insulin-stimulated skeletal muscle.

Authors:  D J Dean; J T Brozinick; S W Cushman; G D Cartee
Journal:  Am J Physiol       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.